Phase II study of rituximab in patients with severe systemic lupus erythematosus
Phase of Trial: Phase II
Latest Information Update: 14 Dec 2010
At a glance
- Drugs Rituximab (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- Sponsors Zenyaku Kogyo
- 14 Dec 2010 Last checked against University Hospital Medical Information Network - Japan.
- 06 Dec 2010 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 16 Oct 2009 New trial record.